Middle East Fertility Society Journal

Table 2 The baseline characteristics of the studied cases

Parameters	Group 1	Group 2	p value
¹Age (years)	29. ± 4.2	28.5 ± 4.3	.0.09
BMI (kg/m²)	27.2 ± 2.05	26.9 ± 2.06	.294
Basal FSH (μ/m)	7.7 ± 3.2	8.1 ± 2.0	0.141
Basal LH (μ/m)	7.0 ± 3.0	7.2 ± 2.6	0.413
Basal E2 (pg/ml)	37.0 ± 8.1	38.4 ± 7.7	0.069
Total dose of gonadotrophin	1901.7 ± 400.6	1789.7 ± 368.6	0.004*
Duration of stimulation	11.3 ± 0.8	10.3 ± 1.1	0.017*
E2 at hCG day	2672.3 ± 768.3	2528.7 ± 611.4	0.039*

There were no significant differences reported between both groups in view of patients’ ages (means 29 vs. 28.5 with p = 0.09), BMI (means 27.2 vs. 26.9 with p = 0.294), and levels of basal hormones (means of FSH, LH, and E2 were, 7.7 vs. 8.1, 7 vs. 7.2, and 37 vs. 38, respectively, with p values = 0.141, 0.413, and 0.69) for groups 1 and 2, respectively). There were significant differences between both groups in view of the total stimulation dose (means, 1901.7 vs. 1789.7 with p = 0.004), the duration of stimulation (means 11.3 vs. 10.3 with p = 0.017), and the E2 levels at hCG day (means, 2672.3 vs. 2528.7 with p = 0.039) in groups 1 and 2
*Significant if p ≤ .05. Independent t test and chi-square test were used for comparison
¹Quantitative data was represented by mean and standard deviation, and qualitative data was represented by frequency and or percentage